Posted by Michael Wonder on 23 Nov 2020
Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28)
23 November 2020 - Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28) will be fully funded from 14 December 2020 until 28 February 2021.
Until now Mercilon 28 has been partially funded for most patients or fully funded as a second line treatment for low income patients.
